302 related articles for article (PubMed ID: 30026011)
1. Chronic exposure to cannabinoids before an emotional trauma may have negative effects on emotional function.
Sbarski B; Akirav I
Eur Neuropsychopharmacol; 2018 Aug; 28(8):955-969. PubMed ID: 30026011
[TBL] [Abstract][Full Text] [Related]
2. Cannabinoids prevent the effects of a footshock followed by situational reminders on emotional processing.
Korem N; Akirav I
Neuropsychopharmacology; 2014 Nov; 39(12):2709-22. PubMed ID: 24897957
[TBL] [Abstract][Full Text] [Related]
3. Chronic treatment with URB597 ameliorates post-stress symptoms in a rat model of PTSD.
Fidelman S; Mizrachi Zer-Aviv T; Lange R; Hillard CJ; Akirav I
Eur Neuropsychopharmacol; 2018 May; 28(5):630-642. PubMed ID: 29519609
[TBL] [Abstract][Full Text] [Related]
4. Cannabinoids and traumatic stress modulation of contextual fear extinction and GR expression in the amygdala-hippocampal-prefrontal circuit.
Ganon-Elazar E; Akirav I
Psychoneuroendocrinology; 2013 Sep; 38(9):1675-87. PubMed ID: 23433741
[TBL] [Abstract][Full Text] [Related]
5. The effects of cannabinoid receptors activation and glucocorticoid receptors deactivation in the amygdala and hippocampus on the consolidation of a traumatic event.
Shoshan N; Akirav I
Neurobiol Learn Mem; 2017 Oct; 144():248-258. PubMed ID: 28818702
[TBL] [Abstract][Full Text] [Related]
6. Cannabinoids prevent the differential long-term effects of exposure to severe stress on hippocampal- and amygdala-dependent memory and plasticity.
Shoshan N; Segev A; Abush H; Mizrachi Zer-Aviv T; Akirav I
Hippocampus; 2017 Oct; 27(10):1093-1109. PubMed ID: 28667676
[TBL] [Abstract][Full Text] [Related]
7. Cannabinoids prevent the development of behavioral and endocrine alterations in a rat model of intense stress.
Ganon-Elazar E; Akirav I
Neuropsychopharmacology; 2012 Jan; 37(2):456-66. PubMed ID: 21918506
[TBL] [Abstract][Full Text] [Related]
8. Cannabinoids prevent depressive-like symptoms and alterations in BDNF expression in a rat model of PTSD.
Burstein O; Shoshan N; Doron R; Akirav I
Prog Neuropsychopharmacol Biol Psychiatry; 2018 Jun; 84(Pt A):129-139. PubMed ID: 29458190
[TBL] [Abstract][Full Text] [Related]
9. The effects of enhancing endocannabinoid signaling and blocking corticotrophin releasing factor receptor in the amygdala and hippocampus on the consolidation of a stressful event.
Aisenberg N; Serova L; Sabban EL; Akirav I
Eur Neuropsychopharmacol; 2017 Sep; 27(9):913-927. PubMed ID: 28663121
[TBL] [Abstract][Full Text] [Related]
10. The involvement of cannabinoids and mTOR in the reconsolidation of an emotional memory in the hippocampal-amygdala-insular circuit.
Zubedat S; Akirav I
Eur Neuropsychopharmacol; 2017 Apr; 27(4):336-349. PubMed ID: 28131675
[TBL] [Abstract][Full Text] [Related]
11. Repeated social defeat-induced neuroinflammation, anxiety-like behavior and resistance to fear extinction were attenuated by the cannabinoid receptor agonist WIN55,212-2.
Lisboa SF; Niraula A; Resstel LB; Guimaraes FS; Godbout JP; Sheridan JF
Neuropsychopharmacology; 2018 Aug; 43(9):1924-1933. PubMed ID: 29786066
[TBL] [Abstract][Full Text] [Related]
12. Role of beta-catenin and endocannabinoids in the nucleus accumbens in extinction in rats exposed to shock and reminders.
Korem N; Lange R; Hillard CJ; Akirav I
Neuroscience; 2017 Aug; 357():285-294. PubMed ID: 28624572
[TBL] [Abstract][Full Text] [Related]
13. Cannabinoid receptor activation prevents the effects of chronic mild stress on emotional learning and LTP in a rat model of depression.
Segev A; Rubin AS; Abush H; Richter-Levin G; Akirav I
Neuropsychopharmacology; 2014 Mar; 39(4):919-33. PubMed ID: 24141570
[TBL] [Abstract][Full Text] [Related]
14. Bi-directional cannabinoid signalling in the basolateral amygdala controls rewarding and aversive emotional processing via functional regulation of the nucleus accumbens.
Ahmad T; Sun N; Lyons D; Laviolette SR
Addict Biol; 2017 Sep; 22(5):1218-1231. PubMed ID: 27230434
[TBL] [Abstract][Full Text] [Related]
15. Neuropeptide Y and cannabinoids interaction in the amygdala after exposure to shock and reminders model of PTSD.
Maymon N; Mizrachi Zer-Aviv T; Sabban EL; Akirav I
Neuropharmacology; 2020 Jan; 162():107804. PubMed ID: 31622603
[TBL] [Abstract][Full Text] [Related]
16. Enhancing Endocannabinoid Neurotransmission Augments The Efficacy of Extinction Training and Ameliorates Traumatic Stress-Induced Behavioral Alterations in Rats.
Morena M; Berardi A; Colucci P; Palmery M; Trezza V; Hill MN; Campolongo P
Neuropsychopharmacology; 2018 May; 43(6):1284-1296. PubMed ID: 29265107
[TBL] [Abstract][Full Text] [Related]
17. Cannabinoid receptor activation in the basolateral amygdala blocks the effects of stress on the conditioning and extinction of inhibitory avoidance.
Ganon-Elazar E; Akirav I
J Neurosci; 2009 Sep; 29(36):11078-88. PubMed ID: 19741114
[TBL] [Abstract][Full Text] [Related]
18. Role of endocannabinoids in the hippocampus and amygdala in emotional memory and plasticity.
Segev A; Korem N; Mizrachi Zer-Aviv T; Abush H; Lange R; Sauber G; Hillard CJ; Akirav I
Neuropsychopharmacology; 2018 Sep; 43(10):2017-2027. PubMed ID: 29977073
[TBL] [Abstract][Full Text] [Related]
19. Long lasting effects of chronic WIN55,212-2 treatment on mesostriatal dopaminergic and cannabinoid systems in the rat brain.
Perdikaris P; Tsarouchi M; Fanarioti E; Natsaridis E; Mitsacos A; Giompres P
Neuropharmacology; 2018 Feb; 129():1-15. PubMed ID: 29113897
[TBL] [Abstract][Full Text] [Related]
20. Cannabinoids elicit antidepressant-like behavior and activate serotonergic neurons through the medial prefrontal cortex.
Bambico FR; Katz N; Debonnel G; Gobbi G
J Neurosci; 2007 Oct; 27(43):11700-11. PubMed ID: 17959812
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
